Sergei I Syrbu MD PhD

PubMed

• Real-world impact of differences in the WHO and ICC classifications of non-Hodgkin lymphoma: a LEO cohort study analysis.
  Brooj Abro, Matthew J Maurer, Thomas M Habermann, W Richard Burack, Jennifer R Chapman
  Blood. 2024-11-07
• Romiplostim for Treatment of Children and Young Adults With Severe Aplastic Anemia and Myelodysplastic Syndrome.
  Anjali Sharathkumar, Jamie Carr, David Claassen, Sergei Syrbu, Sharathkumar Bhagavathi
  Journal of Pediatric Hematology/oncology. 2024-07-01
• 6 citations
  The Lymphoma Epidemiology of Outcomes cohort study: Design, baseline characteristics, and early outcomes.
  James R Cerhan, Matthew J Maurer, Brian K Link, Andrew L Feldman, Thomas M Habermann
  American Journal of Hematology. 2024-03-01

Abstracts/Posters

• Intrafollicular CD4+ T-Cells As an Independent Predictor of Early Clinical Failure in Newly Diagnosed Follicular Lymphoma
  Sergei Syrbu, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Event-Free Survival at 24 Months Following Autologous Stem Cell Transplant in Diffuse Large B-Cell Lymphoma
  Sergei Syrbu, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Prevalence and the Impact of Hypogammaglobulinemia in Newly Diagnosed, Untreated Diffuse Large B Cell Lymphoma
  Sergei Syrbu, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Lectures

• The Lymphoma Epidemiology of Outcomes (LEO) Cohort Study Reflects the Demographics and Subtypes of Patients Diagnosed with Non-Hodgkin Lymphoma in the United States 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018